Exploring Markers and Molecular Pathogenesis of Cancer: Genitourinary and Gynecological Tumors
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (25 February 2024) | Viewed by 1458
Special Issue Editor
Interests: molecular pathology; prostate cancer; biomarkers research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the realm of hematology and oncology, cancer remains a complex and pressing healthcare challenge, demanding innovative insights into its molecular underpinnings. Molecular and genetic factors have been shown to exert a profound influence on tumor behavior, treatment responses, and patient outcomes. However, there exists a critical gap in our understanding where the molecular underpinnings of tumor progression intersect with traditional pathological assessments. Addressing this gap is essential for tailoring therapies to individual patients and optimizing treatment efficacy. We propose a Special Issue dedicated to unraveling the intricacies of genitourinary and gynecological tumors. This Special Issue will delve into the latest advancements in understanding prostate, endometrial, bladder, penile, urothelial, cervical, and ovarian cancers, among others. The primary focus will be on molecular pathology, elucidating the intricate mechanisms driving these malignancies. We aim to shed light on novel biomarkers, diagnostic tools, and therapeutic targets to advance precision medicine and improve patient outcomes. In this Special Issue, we invite researchers in cancer biology, pathology, hematology–oncology, and other fields of cancer research to contribute original research articles, reviews, and communications that shed light on the nexus between molecular insights and the pathology of grading and staging in cancers.
Dr. Hisham Bahmad
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- prostate
- bladder
- endometrial cancer
- ovarian cancer
- cervical cancer
- renal cancer
- urothelial carcinoma
- biomarkers
- therapeutic target
- personalized medicine
- targeted therapy
- molecular signatures
- diagnosis
- prognosis
